Transcutaneous PO2 monitoring in infants with persistent fetal circulation who are receiving tolazoline therapy.
D006330:Heart Defects, Congenital / Q000097:blood / Q000188:drug therapy; D006801:Humans; D007231:Infant, Newborn; D008991:Monitoring, Physiologic; D010100:Oxygen / Q000097:blood*; D010313:Partial Pressure; D014043:Tolazoline / Q000009:adverse effects / Q000627:therapeutic use*
D014043:Tolazoline; D010100:Oxygen